SUV39H2 and neoplasm: These findings suggest that targeting SUV39H2 represents a promising strategy to overcome oHSV-1 resistance in OSCC, providing potential for combination therapies in anti-tumor treatment and for identifying biomarkers that could predict the efficiency of oHSV-1 replication in tumors.